(Q44843303)

6 December 2017

title

Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats (English)

1 reference

6 December 2017

1 reference

Jianmin Ran

1

1 reference

6 December 2017

Tsutomu Hirano

series ordinal

2

1 reference

6 December 2017

Mitsuru Adachi

series ordinal

3

1 reference

6 December 2017

publication date

13 April 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

6 December 2017

published in

1 reference

6 December 2017

volume

287

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

E227-32

1 reference

Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Effect of fatty acids on glucose production and utilization in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Hepatic lipid metabolism in severe human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Lipoprotein lipase and cholesterol transfer activities of lean and obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Insulin resistance: a chicken that has come to roost

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00090.2004

10.1152/AJPENDO.00090.2004

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference